IsleCare

Vitiligo exposes patients to a heightened risk of developing various diseases that impact the body's immune system. The number of vitiligo patients worldwide is substantial, and the figure is increasing. Besides physical discomfort, vitiligo patients are frequently misunderstood by others, and even discriminated against, also facing a significant psychological burden. As a result, the probability of vitiligo patients suffering from depression is 7 to 10 times that of ordinary people. Moreover, vitiligo is a chronic skin disorder, and its treatment process often requires a prolonged period.



During the long-term treatment course, patients should not only actively collaborate in the treatment of the disease but also proactively pay attention to health management to enhance the treatment outcome and quality of life. A common treatment is light therapy at home, but patients usually feel difficult to adhere to, and can't find changes through the naked eye in time.



IsleCare comes to the rescue.



Using advanced AI image analysis, IsleCare examines white spots and generates visual reports to track changes. Meanwhile, it provides positive feedback by simulating visual effect of the island's ecological improvement, reducing the loneliness and anxiety of patients in long-term treatment.



The UV light therapy uses an LED light source with a peak wavelength of 308 ±2nm. Slightly larger than a remote control, it's designed for easy single-user operation. The device automatically shows the previous dosage in the app, allowing for simple adjustment based on skin response. It also features interchangeable therapy heads to meet different treatment area and intensity needs.



IsleCare plays the role of a long-term companion by continuously documenting and providing feedback on the user's therapy sessions. It focuses not only on the immediate results of the treatment, but also on the long-term health and growth of the user, encouraging users to witness and celebrate every small health improvement with IsleCare.